• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    FleishmanHillard Appoints Mary Kosinski as Global Managing Director of Health and Life Sciences

    1/7/25 11:00:00 AM ET
    $OMC
    Advertising
    Consumer Discretionary
    Get the next $OMC alert in real time by email

    Agency Expands Sector Leadership Team Announcing Additional Senior Roles

    ST. LOUIS, Jan. 7, 2025 /PRNewswire/ -- FleishmanHillard today announced that Mary Kosinski has joined the agency as global managing director of Health and Life Sciences effective immediately. Kosinski will lead FleishmanHillard's largest sector and be responsible for driving transformation, expanding focus and delivering integrated solutions for clients.

    FleishmanHillard Logo (PRNewsfoto/FleishmanHillard)

    "Mary's energy and deep regulatory and policy experience will bring tremendous insights to our clients and fresh perspectives to our team," said Mark Mortell, global head of practices and sectors for FleishmanHillard. "Her background in government agencies complements FleishmanHillard's strong healthcare credentials and expertise across the sector."

    Before joining FleishmanHillard Kosinski served in multiple regulatory, advocacy and public health advisory roles. Most recently as the head of global corporate affairs for Pi Health and previously at the Pharmaceutical Research and Manufacturers of America. For nearly 15 years, Mary worked both domestically and overseas with the U.S. Department of Health and Human Services, including the Centers for Medicare and Medicaid Services, the Assistant Secretary for Preparedness and Response, and was the first chief of staff at the Biomedical Advanced Research and Development Authority.

    In addition to Kosinski's appointment, the agency announced three new leadership roles within Health and Life Sciences:

    • John Gisborne as the sector's global head of strategic client partnerships expanding client relationships and building strategic opportunities.
    • Marc Longpre as global head of strategy and insights for the sector, building up agency capabilities and key areas of expertise.
    • Jenyne Engelhardt as global head of operations and integration for the sector, driving efficiency, service integration and talent engagement.

    These senior leaders bring deep industry expertise, have led client teams and have served as counselors for clients across FleishmanHillard's global health network. Kosinski and the new sector leadership team will work to diversify the business, ensure career development for agency colleagues and cultivate a culture of client experience excellence.

    Kosinski and the leadership team will be working closely with other global and regional health leaders across OPRG agencies.

    "I'm excited to join such a dynamic organization and talented team at such a pivotal moment for the healthcare industry," said Kosinski. "The pace of change is unlike any other in healthcare's history – digital transformation, Gen AI, patient-centered care and novel drugs and therapeutics are all contributing to a new era where communications is vital in helping clients meet patient and consumer expectations. FleishmanHillard's deep health and life sciences experience will ensure we're ready to help clients achieve their goals and navigate the challenges they face with the agility, thought leadership and expert support they need."

    FleishmanHillard's Health and Life Sciences sector is FleishmanHillard's largest, providing expert counsel and communications support for healthcare clients' needs across reputation, product brand building, patient and healthcare professional engagement, public affairs, crisis communications, social and innovation, research and media relations. 

    Today's announcement follows the appointment of J.J. Carter to president and CEO of the agency in October 2024, and his new global leadership team in November 2024, reflecting FleishmanHillard's transformation and expanded focus on the use of intelligence and technology. Kosinski's appointment marks the agency's continued commitment to deliver specialist senior counsel and leadership in key sectors.

    About FleishmanHillard 

    FleishmanHillard specializes in public relations, reputation management, public affairs, brand marketing, digital strategy, social engagement and content strategy. FleishmanHillard was named 2020, 2021 and 2022 Campaign Global PR Agency of the Year; 2023 ICCO Large Agency of the Year – The Americas; 2022 and 2023 PRWeek U.S. Agency of the Year; 2022 and 2023 PRWeek U.S. Outstanding Extra-Large Agency of the Year; 2023 Campaign US PR Agency of the Year; 2021 PRovoke APAC Consultancy of the Year; and 2021 PRWeek UK Large Consultancy of the Year. FleishmanHillard is part of Omnicom PR Group and has nearly 80 offices in more than 30 countries, plus affiliates in 45 countries. 

    About Omnicom PR Group (OPRG)

    Omnicom PR Group (OPRG) is the largest global network of communications and consulting agencies in the world. It is home to three of the top global PR agencies FleishmanHillard, Ketchum, Porter Novelli and more than a dozen specialist agencies in corporate and public affairs, political consulting and advertising, language strategy, global health strategy and organizational transformation. OPRG is part of Omnicom (NYSE:OMC). www.TeamOPRG.com.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/fleishmanhillard-appoints-mary-kosinski-as-global-managing-director-of-health-and-life-sciences-302344294.html

    SOURCE FleishmanHillard

    Get the next $OMC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $OMC

    DatePrice TargetRatingAnalyst
    6/25/2025$80.00Overweight → Equal Weight
    Barclays
    6/23/2025$80.00Underperform → Neutral
    BofA Securities
    2/14/2025Buy → Hold
    Argus
    10/16/2024$118.00 → $119.00Overweight
    JP Morgan
    10/16/2024$106.00 → $110.00Overweight → Equal Weight
    Wells Fargo
    5/7/2024$100.00 → $110.00Equal Weight → Overweight
    Barclays
    4/17/2024$91.00 → $106.00Equal Weight → Overweight
    Wells Fargo
    4/2/2024$100.00 → $110.00Outperform
    Macquarie
    More analyst ratings

    $OMC
    SEC Filings

    See more
    • SEC Form 11-K filed by Omnicom Group Inc.

      11-K - OMNICOM GROUP INC. (0000029989) (Filer)

      6/30/25 4:01:36 PM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Omnicom Group Inc. filed SEC Form 8-K: Other Events

      8-K - OMNICOM GROUP INC. (0000029989) (Filer)

      6/23/25 5:21:00 PM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Omnicom Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - OMNICOM GROUP INC. (0000029989) (Filer)

      5/14/25 5:25:51 PM ET
      $OMC
      Advertising
      Consumer Discretionary

    $OMC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Kristin Hollins Appointed FleishmanHillard California General Manager

      Agency Veteran and Strategic Advisor to Global Brands Will Lead Growth and Innovation Across West Coast ST. LOUIS, July 10, 2025 /PRNewswire/ -- FleishmanHillard today announced the appointment of Kristin Hollins as general manager for California. In this role, Hollins will oversee the agency's strategy and operations across San Francisco, Los Angeles, San Diego, Orange County and Sacramento, with a focus on client experience, growth, talent development and cross-market integration. She will report to Della Sweetman, president, Americas and chief strategy officer. Hollins brin

      7/10/25 9:03:00 AM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Omnicom Schedules Second Quarter 2025 Earnings Release and Conference Call

      NEW YORK, July 9, 2025 /PRNewswire/ -- Omnicom (NYSE:OMC) will publish its second quarter 2025 results on Tuesday, July 15, 2025 after the New York Stock Exchange close of trading. The company will also host a conference call to review such financial results on Tuesday, July 15, 2025, starting at 4:30 p.m. Eastern Time. A live webcast of the call will be available at Omnicom's investor relations website, investor.omnicomgroup.com, along with the related earnings press release and slide presentation. A webcast replay will be made available after the call concludes. About OmnicomOmnicom (NYSE:OMC) is a leading provider of data-inspired, creative marketing and sales solutions. Omnicom's iconic

      7/9/25 4:30:00 PM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

      Omnicom cross-agency collaboration to drive technology-led, innovative launch strategy Partnership brings together promising science, top-tier talent, and advanced technologies to enable a faster, smarter, and more effective path to address a critical public health need SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced it has named Omnicom (NYSE:OMC) as its strategic innovation partner and agency of record to lead initiatives in

      6/26/25 4:02:00 PM ET
      $ACHV
      $OMC
      Biotechnology: In Vitro & In Vivo Diagnostic Substances
      Health Care
      Advertising
      Consumer Discretionary

    $OMC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Omnicom downgraded by Barclays with a new price target

      Barclays downgraded Omnicom from Overweight to Equal Weight and set a new price target of $80.00

      6/25/25 7:52:17 AM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Omnicom upgraded by BofA Securities with a new price target

      BofA Securities upgraded Omnicom from Underperform to Neutral and set a new price target of $80.00

      6/23/25 8:01:50 AM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Omnicom downgraded by Argus

      Argus downgraded Omnicom from Buy to Hold

      2/14/25 8:36:38 AM ET
      $OMC
      Advertising
      Consumer Discretionary

    $OMC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Senior VP, Gen. Counsel & Sec. Januzzi Louis F was granted 6,770 shares, increasing direct ownership by 23% to 35,728 units (SEC Form 4)

      4 - OMNICOM GROUP INC. (0000029989) (Issuer)

      7/3/25 4:50:22 PM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Director Gerstein Mark D was granted 1,025 shares, increasing direct ownership by 9% to 12,020 units (SEC Form 4)

      4 - OMNICOM GROUP INC. (0000029989) (Issuer)

      7/3/25 4:33:04 PM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Director Coleman Leonard S Jr was granted 712 shares, increasing direct ownership by 2% to 46,463 units (SEC Form 4)

      4 - OMNICOM GROUP INC. (0000029989) (Issuer)

      7/3/25 4:32:48 PM ET
      $OMC
      Advertising
      Consumer Discretionary

    $OMC
    Leadership Updates

    Live Leadership Updates

    See more
    • Kristin Hollins Appointed FleishmanHillard California General Manager

      Agency Veteran and Strategic Advisor to Global Brands Will Lead Growth and Innovation Across West Coast ST. LOUIS, July 10, 2025 /PRNewswire/ -- FleishmanHillard today announced the appointment of Kristin Hollins as general manager for California. In this role, Hollins will oversee the agency's strategy and operations across San Francisco, Los Angeles, San Diego, Orange County and Sacramento, with a focus on client experience, growth, talent development and cross-market integration. She will report to Della Sweetman, president, Americas and chief strategy officer. Hollins brin

      7/10/25 9:03:00 AM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Adrienne Connell Appointed Managing Director of FleishmanHillard Canada

      Experienced Agency Leader to Guide Agency's Growth and Integration in Canada ST. LOUIS, June 24, 2025 /PRNewswire/ -- FleishmanHillard today announced the appointment of Adrienne Connell as managing director of its Canada operations. Connell will oversee strategic direction, growth and client service across the agency's Canadian markets as the firm continues to evolve its presence in the region. She will report to Della Sweetman, president, Americas and chief strategy officer. The appointment coincides with the agency's rebrand from FleishmanHillard Highroad in the region to F

      6/24/25 8:45:00 AM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Susan Catalano Joins Omnicom as Chief People Officer for the U.S.

      NEW YORK, May 7, 2025 /PRNewswire/ -- Omnicom (NYSE:OMC) today announced the appointment of Susan Catalano as Chief People Officer. In this newly created position, Catalano is responsible for leading the company's human resource (HR) organization and operations in the U.S., overseeing a dedicated team of HR professionals. She reports directly to Omnicom's Chairman and CEO John Wren. Catalano is a strategic HR leader bringing extensive global experience and a track record for managerial and operational excellence and strong decision making. She is an expert in driving large-scale transformational change through organizational re-design, talent management, and operations. She has successfully

      5/7/25 12:39:00 PM ET
      $OMC
      Advertising
      Consumer Discretionary

    $OMC
    Financials

    Live finance-specific insights

    See more
    • Omnicom Schedules Second Quarter 2025 Earnings Release and Conference Call

      NEW YORK, July 9, 2025 /PRNewswire/ -- Omnicom (NYSE:OMC) will publish its second quarter 2025 results on Tuesday, July 15, 2025 after the New York Stock Exchange close of trading. The company will also host a conference call to review such financial results on Tuesday, July 15, 2025, starting at 4:30 p.m. Eastern Time. A live webcast of the call will be available at Omnicom's investor relations website, investor.omnicomgroup.com, along with the related earnings press release and slide presentation. A webcast replay will be made available after the call concludes. About OmnicomOmnicom (NYSE:OMC) is a leading provider of data-inspired, creative marketing and sales solutions. Omnicom's iconic

      7/9/25 4:30:00 PM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Omnicom Declares Dividend

      NEW YORK, May 6, 2025 /PRNewswire/ -- The Board of Directors of Omnicom (NYSE: OMC) declared a quarterly dividend of 70 cents per outstanding share of the corporation's common stock. The dividend is payable on July 9, 2025 to Omnicom common shareholders of record at the close of business on June 10, 2025. About OmnicomOmnicom (NYSE: OMC) is a leading provider of data-inspired, creative marketing and sales solutions. Omnicom's iconic agency brands are home to the industry's most innovative communications specialists who are focused on driving intelligent business outcomes for their clients. The company offers a wide range of services in advertising, strategic media planning and buying, preci

      5/6/25 4:31:00 PM ET
      $OMC
      Advertising
      Consumer Discretionary
    • Omnicom Reports First Quarter 2025 Results

      2025 First Quarter: Revenue of $3.7 billion, with organic growth of 3.4%Net income of $287.7 millionDiluted earnings per share of $1.45; $1.70 Non-GAAP adjustedOperating income of $452.6 million; Non-GAAP Adj. EBITA of $508.2 million with 13.8% marginNEW YORK, April 15, 2025 /PRNewswire/ -- Omnicom (NYSE:OMC) today announced results for the quarter ended March 31, 2025. "Organic revenue growth for the first quarter was 3.4%. We are assessing the implications of economic and market events to determine how they will affect our clients and business for the remainder of 2025. While uncertainty has increased, one thing hasn't changed and will always be true – Omnicom is a trusted partner for our

      4/15/25 4:03:00 PM ET
      $OMC
      Advertising
      Consumer Discretionary

    $OMC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Omnicom Group Inc.

      SC 13G - OMNICOM GROUP INC. (0000029989) (Subject)

      11/8/24 10:46:38 AM ET
      $OMC
      Advertising
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Omnicom Group Inc. (Amendment)

      SC 13G/A - OMNICOM GROUP INC. (0000029989) (Subject)

      2/9/23 11:27:46 AM ET
      $OMC
      Advertising
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Omnicom Group Inc. (Amendment)

      SC 13G/A - OMNICOM GROUP INC. (0000029989) (Subject)

      2/10/22 8:28:05 AM ET
      $OMC
      Advertising
      Consumer Discretionary